My PD Story
Gabor G. Kovacs, MD, PhD, FRCPC
2026 Impact Award
3D Mapping the Brain to Study Non-movement Parkinson’s Symptoms
While most people know Parkinson’s disease (PD) for its movement symptoms, PD also causes a wide range of non-movement symptoms. Some non-movement (or non-motor) symptoms, such as dizziness, problems with automatic body functions (such as blood pressure control), constipation, depression and sleep disturbances, often appear many years before the movement symptoms begin.
Research suggests that many of these early non-movement symptoms are controlled by a region of the brain called the locus coeruleus (LC), which produces and supplies noradrenaline, a chemical messenger that helps regulate alertness, mood and sleep. It also helps influence automatic body functions, such as blood pressure and heart rate, through connections with other parts of the brain and spinal cord. In PD, the LC is one of the earliest places where degeneration begins in the brain, which may underly the early appearance of non-movement PD symptoms.
Gabor G. Kovacs, MD, PhD, FRCPC, recipient of a Parkinson’s Foundation Impact Award, will investigate the LC of brains donated by people with PD. His goal is to assess how PD affects the LC biologically and if it could be the key to earlier detection of the disease.
“This project aims to identify a biological ‘signature’ of early damage in the LC, which could improve MRI methods for detecting Parkinson’s earlier in life.” – Dr. Kovacs
In PD, clumps of a misfolded protein called alpha-synuclein disrupt fragile neurons in the brain, leading to their eventual degeneration. However, studies suggest that the cognitive symptoms of PD and other diseases are linked to buildup of another protein called tau. Dr. Kovacs and his team at the University of Toronto in Canada will analyze donated brain tissue from people who had early or late-stage PD. While donated brain tissue can usually only be seen in thin slices, Dr. Kovacs’s team will use powerful imaging technology to visualize larger pieces of the brain, creating 3D biological maps of the LC and other brain regions.
From these maps, Dr. Kovacs will investigate how buildup of alpha-synuclein and tau accumulate in the LC in early- versus late-stage PD. Understanding where these clumps first occur and how they spread could explain when non-movement symptoms develop. These 3D maps will let Dr. Kovacs observe if misfolded protein buildup affects the flow of blood and cerebrospinal fluid in the brain as well. The LC plays a role in regulating these processes through its nerve connections to blood vessels and to cells involved in producing and moving cerebrospinal fluid. By examining these connections, they hope to better understand how PD disrupts the brain’s circulation and overall health.
These experiments could reveal new ways to identify PD early in its progression and provide early clues to how non-movement PD symptoms develop. In addition, this research could lead to MRI scanning procedures that could spot signs of PD in the LC years before movement symptoms occur.
“This award will support a methodological leap for my research program, positioning it to generate the kind of high-resolution spatial data needed to advance our understanding of Parkinson’s,” said Dr. Kovacs. “These findings will support more targeted, stage-appropriate pharmacotherapies and stratified treatment strategies for PD.”
Meet more Parkinson’s researchers! Explore our My PD Stories featuring PD researchers.
Related Materials
More Stories
from the Parkinson's community